BDBM404299 2-{5-[(3R,6R)-6-Methyl-1-{[2- (2H-tetrazol-2- yl)phenyl]carbonyl}piperidin-3- yl]isoxazol-3-yl}propan-2-ol::US10017504, 32

SMILES C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1ncnn1)c1cc(no1)C(C)(C)O

InChI Key InChIKey=ZYPYZPZKZGDVIP-ZIAGYGMSSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 404299   

TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM404299(2-{5-[(3R,6R)-6-Methyl-1-{[2- (2H-tetrazol-2- yl)p...)
Affinity DataIC50: >1.00E+4nMAssay Description:n a typical experiment the OX1 and OX2 receptor antagonistic activity of the compounds of the present invention was determined in accordance with the...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM404299(2-{5-[(3R,6R)-6-Methyl-1-{[2- (2H-tetrazol-2- yl)p...)
Affinity DataIC50:  124nMAssay Description:n a typical experiment the OX1 and OX2 receptor antagonistic activity of the compounds of the present invention was determined in accordance with the...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent